You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

NYSTATIN AND TRIAMCINOLONE ACETONIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Nystatin And Triamcinolone Acetonide patents expire, and what generic alternatives are available?

Nystatin And Triamcinolone Acetonide is a drug marketed by Alembic, Alpharma Us Pharms, Amneal, Crown Labs Inc, Dr Reddys, Fougera Pharms Inc, Glenmark Pharms Ltd, Lupin Ltd, Macleods Pharms Ltd, Padagis Israel, Perrigo New York, Pharmafair, Taro, Torrent, Chartwell Rx, Epic Pharma Llc, Pai Holdings Pharm, Rising, Strides Pharma, and Zydus Lifesciences. and is included in thirty-one NDAs.

The generic ingredient in NYSTATIN AND TRIAMCINOLONE ACETONIDE is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Nystatin And Triamcinolone Acetonide

A generic version of NYSTATIN AND TRIAMCINOLONE ACETONIDE was approved as nystatin; triamcinolone acetonide by FOUGERA PHARMS INC on October 8th, 1985.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NYSTATIN AND TRIAMCINOLONE ACETONIDE?
  • What are the global sales for NYSTATIN AND TRIAMCINOLONE ACETONIDE?
  • What is Average Wholesale Price for NYSTATIN AND TRIAMCINOLONE ACETONIDE?
Summary for NYSTATIN AND TRIAMCINOLONE ACETONIDE
Drug patent expirations by year for NYSTATIN AND TRIAMCINOLONE ACETONIDE
Pharmacology for NYSTATIN AND TRIAMCINOLONE ACETONIDE

US Patents and Regulatory Information for NYSTATIN AND TRIAMCINOLONE ACETONIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rising NYSTATIN AND TRIAMCINOLONE ACETONIDE nystatin; triamcinolone acetonide OINTMENT;TOPICAL 206785-001 Dec 29, 2016 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Strides Pharma NYSTATIN AND TRIAMCINOLONE ACETONIDE nystatin; triamcinolone acetonide OINTMENT;TOPICAL 210077-001 Jan 29, 2018 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alembic NYSTATIN AND TRIAMCINOLONE ACETONIDE nystatin; triamcinolone acetonide CREAM;TOPICAL 214090-001 Mar 31, 2021 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Crown Labs Inc NYSTATIN AND TRIAMCINOLONE ACETONIDE nystatin; triamcinolone acetonide OINTMENT;TOPICAL 207731-001 Dec 26, 2017 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.